Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-26-025433
Filing Date
2026-03-10
Accepted
2026-03-10 08:11:23
Documents
99
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0277639-10k_protara.htm   iXBRL 10-K 1598766
2 SECOND AMENDMENT TO SUBSCRIPTION AGREEMENT, DATED DECEMBER 17, 2025, BY AND AMON ea027763901ex10-4_protara.htm EX-10.4 26919
3 LIST OF SUBSIDIARIES ea027763901ex21-1_protara.htm EX-21.1 3812
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea027763901ex23-1_protara.htm EX-23.1 5580
5 CERTIFICATION ea027763901ex31-1_protara.htm EX-31.1 11208
6 CERTIFICATION ea027763901ex31-2_protara.htm EX-31.2 11202
7 CERTIFICATION ea027763901ex32-1_protara.htm EX-32.1 5829
8 GRAPHIC image_001.jpg GRAPHIC 165486
9 GRAPHIC image_002.jpg GRAPHIC 21100
10 GRAPHIC image_003.jpg GRAPHIC 24571
  Complete submission text file 0001213900-26-025433.txt   8453552

Data Files

Seq Description Document Type Size
11 XBRL PRESENTATION FILE tara-20251231_pre.xml EX-101.PRE 370537
12 XBRL SCHEMA FILE tara-20251231.xsd EX-101.SCH 82051
13 XBRL CALCULATION FILE tara-20251231_cal.xml EX-101.CAL 68021
14 XBRL DEFINITION FILE tara-20251231_def.xml EX-101.DEF 334275
15 XBRL LABEL FILE tara-20251231_lab.xml EX-101.LAB 692543
102 EXTRACTED XBRL INSTANCE DOCUMENT ea0277639-10k_protara_htm.xml XML 852645
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36694 | Film No.: 26737291
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)